Using stem cells from umbilical cord blood and bone marrow, researchers apparently have cured a fatal genetic disease in a 2-year-old Minneapolis boy, a feat that could open the door for a variety of stem cell treatments.
For the first time in his life, Nate Liao is wearing normal clothes, eating food that has not been pureed and playing with his siblings.
"Nate's quality of life is forever changed," said Dr. John Wagner of the University of Minnesota Medical School, who performed the treatment. "Maybe we can take one more disorder off the incurable list."
The team subsequently has treated Nate's 5-year-old brother Jacob and is preparing to treat 9-month-old Sarah Rose Mooreland of Folsom, Calif., and have high hopes for them as well.
Nate suffers from recessive epidermolysis bullosa, a genetic disease that affects one in every 100,000 children. Such children lack a critical protein called collagen type VII that anchors the skin and lining of the gastrointestinal system to the body.
Their skin is extraordinarily fragile. Tearing and blistering occur with minimal friction, leading to painful wounds and scarring. Solid food produces erosion of the esophagus. Death usually results from malnutrition, infections or aggressive skin cancer.
The only treatment previously has been to keep the children wrapped in bandages to protect the skin as much as possible.